XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) (Unaudited) - USD ($)
Series A Preferred Stock [Member]
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 420 $ 2,366 $ 26,107,159 $ (27,443,643) $ (1,333,698)
Beginning Balance, shares at Dec. 31, 2020 42,030,331 236,526,638      
Fair value of vested stock options granted to employees 158,315 158,315
Net loss (936,031) (936,031)
Fair value of vested stock options granted to directors 21,174 21,174
Common shares issued in settlement of legal dispute, shares   1,000,000      
Issuance of series B preferred stock and warrants, net 927,721 927,721
Accrued dividends (1,447) (1,447)
Adjustment to redemption value (2,262,847) (2,262,847)
Common shares issued in settlement of legal dispute 10 66,990 67,000
Ending balance, value at Sep. 30, 2021 $ 420 $ 2,376 25,017,065 (28,379,674) (3,359,813)
Ending Balance, shares at Sep. 30, 2021 42,030,331 237,526,638      
Beginning balance, value at Jun. 30, 2021 $ 420 $ 2,376 26,324,331 (27,971,769) (1,644,642)
Beginning Balance, shares at Jun. 30, 2021 42,030,331 237,526,638      
Fair value of vested stock options granted to employees 14,545 14,545
Net loss (407,905) (407,905)
Fair value of vested stock options granted to directors 14,762 14,762
Issuance of series B preferred stock and warrants, net 927,721 927,721
Accrued dividends (1,447) (1,447)
Adjustment to redemption value (2,262,847) (2,262,847)
Ending balance, value at Sep. 30, 2021 $ 420 $ 2,376 25,017,065 (28,379,674) (3,359,813)
Ending Balance, shares at Sep. 30, 2021 42,030,331 237,526,638      
Beginning balance, value at Dec. 31, 2021 $ 16 25,211,017 (28,781,566) (3,570,533)
Beginning Balance, shares at Dec. 31, 2021   1,600,835      
Fair value of vested stock options granted to employees   208,672 208,672
Fair value of restricted stock units issued to directors   17,418 17,418
Net loss (4,225,578) (4,225,578)
Fair value of vested stock options granted to directors   29,656 29,656
Common shares issued in settlement of restricted stock units issued to directors   $ 0 24,994 24,994
Common shares issued in settlement of restricted stock units issued to directors, shares   3,367      
Issuance of common shares to round up partial shares following reverse split   $ 0 0   0
Common shares issued in settlement of legal dispute, shares   6,798      
Common shares and warrants issued for cash   $ 58 21,711,073 21,711,131
Common shares and warrants issued for cash, shares   5,811,138      
Common shares and warrants issued on conversion of series B preferred stock   $ 4 1,979,996 1,980,000
Common shares issued and warrants on conversion of series B preferred stock, shares   362,306      
Dividends on series B preferred stock   (35,984) (35,984)
Cashless exercise of prefunded warrants   $ 2 (2)
Cashless exercise of prefunded warrants, shares   169,530      
Ending balance, value at Sep. 30, 2022 $ 80 49,146,840 (33,007,144) 16,139,776
Ending Balance, shares at Sep. 30, 2022   7,953,974      
Beginning balance, value at Jun. 30, 2022 $ 80 49,091,496 (31,965,094) 17,126,482
Beginning Balance, shares at Jun. 30, 2022   7,953,974      
Fair value of vested stock options granted to employees   49,099 49,099
Fair value of restricted stock units issued to directors   6,245 6,245
Net loss (1,042,050) (1,042,050)
Ending balance, value at Sep. 30, 2022 $ 80 $ 49,146,840 $ (33,007,144) $ 16,139,776
Ending Balance, shares at Sep. 30, 2022   7,953,974